Cargando…

Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays

Detalles Bibliográficos
Autores principales:	Ferré, Valentine Marie, Lebourgeois, Samuel, Chenane, Houssem Redha, Menidjel, Reyene, Masson, Christelle, Collin, Gilles, Visseaux, Benoit, Descamps, Diane, Fidouh, Nadhira, Charpentier, Charlotte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906917/ https://www.ncbi.nlm.nih.gov/pubmed/35278483 http://dx.doi.org/10.1016/j.jinf.2022.02.031

Ejemplares similares

Alpha (B.1.1.7) and Delta (B.1.617.2 – AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage
por: Lebourgeois, Samuel, et al.
Publicado: (2022)

Decreasing humoral response among healthcare workers up to 4 months after two doses of BNT162b2 vaccine
por: Ferré, Valentine Marie, et al.
Publicado: (2022)

Earlier In Vitro Viral Production With SARS-CoV-2 Alpha Than With Beta, Gamma, B, or A.27 Variants
por: Lebourgeois, Samuel, et al.
Publicado: (2021)

Differential activation of human neutrophils by SARS-CoV-2 variants of concern
por: Lebourgeois, Samuel, et al.
Publicado: (2022)

Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: A feasible alternative approach with low technical requirements
por: Visseaux, Benoit, et al.
Publicado: (2021)

Temporal dynamics of RSV shedding and genetic diversity in adults during the COVID-19 pandemic in a French hospital, early 2021
por: Coppée, Romain, et al.
Publicado: (2022)

Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO performances and limit of detection
por: Visseaux, Benoit, et al.
Publicado: (2020)

Omicron SARS-CoV-2 variant: What we know and what we don’t
por: Ferré, Valentine Marie, et al.
Publicado: (2022)

Usefulness of multiplex PCR methods and respiratory viruses’ distribution in children below 15 years old according to age, seasons and clinical units in France: A 3 years retrospective study
por: Visseaux, Benoit, et al.
Publicado: (2017)

SARS-CoV-2 viability and viral RNA persistence on microbiological agar plates
por: Farfour, E., et al.
Publicado: (2023)

Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott)
por: Charpentier, Charlotte, et al.
Publicado: (2020)

Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses
por: Gounant, Valérie, et al.
Publicado: (2022)

Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the First Rapid Multiplex PCR Commercial Assay for SARS-CoV-2 Detection
por: Visseaux, Benoit, et al.
Publicado: (2020)

Neutralization susceptibility of Omicron lineages
por: Minton, Kirsty
Publicado: (2022)

HIV-2 diversity displays two clades within group A with distinct geographical distribution and evolution
por: Visseaux, Benoit, et al.
Publicado: (2021)

Contribution of rapid lateral flow assays from capillary blood specimens to the diagnosis of COVID-19 in symptomatic healthcare workers: a pilot study in a university hospital, Paris, France
por: Charpentier, Charlotte, et al.
Publicado: (2021)

Impact of Low-Dose Methotrexate–Adalimumab Combination Therapy on the Antibody Response Induced by the mRNA-1273 SARS-CoV-2 Vaccine: Case of an Elderly Patient with Rheumatoid Arthritis
por: Michiels, Yves, et al.
Publicado: (2021)

Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient
por: Michiels, Yves, et al.
Publicado: (2021)

Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against Omicron
por: Hao, Linhui, et al.
Publicado: (2023)

Performance evaluation of the QIAstat-Dx® Respiratory SARS-CoV-2 Panel
por: Lebourgeois, Samuel, et al.
Publicado: (2021)

A Simple and High-Throughput ELISA-Based Neutralization Assay for the Determination of Anti-Flavivirus Neutralizing Antibodies
por: Balingit, Jean Claude, et al.
Publicado: (2020)

Prevalence of respiratory viruses among adults, by season, age, respiratory tract region and type of medical unit in Paris, France, from 2011 to 2016
por: Visseaux, Benoit, et al.
Publicado: (2017)

Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants
por: Wang, Xue-Jun, et al.
Publicado: (2022)

The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients
por: Teyssou, Elisa, et al.
Publicado: (2021)

Impact of respiratory viruses in hospital-acquired pneumonia in the intensive care unit: A single-center retrospective study
por: Loubet, Paul, et al.
Publicado: (2017)

Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays
por: Passariello, Margherita, et al.
Publicado: (2023)

Potent Omicron-neutralizing antibodies isolated from a patient vaccinated 6 months before Omicron emergence
por: Hastie, Kathryn M., et al.
Publicado: (2023)

The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients
por: Teyssou, Elisa, et al.
Publicado: (2021)

Post-Vaccination Neutralization Responses to Omicron Sub-Variants
por: Jacobsen, Henning, et al.
Publicado: (2022)

Delta-Omicron recombinant escapes therapeutic antibody neutralization
por: Duerr, Ralf, et al.
Publicado: (2023)

Neutralization, effector function and immune imprinting of Omicron variants
por: Addetia, Amin, et al.
Publicado: (2023)

Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
por: Zang, Jinkai, et al.
Publicado: (2022)

No association between human herpesvirus or herpesvirus saimiri and idiopathic pulmonary fibrosis
por: Le Hingrat, Quentin, et al.
Publicado: (2020)

An ELISA Platform for the Quantitative Analysis of SARS-CoV-2 RBD-neutralizing Antibodies As an Alternative to Monitoring of the Virus-Neutralizing Activity
por: Kostin, N. N., et al.
Publicado: (2022)

Plasma Neutralization of the SARS-CoV-2 Omicron Variant
por: Schmidt, Fabian, et al.
Publicado: (2021)

Effects of a Prolonged Booster Interval on Neutralization of Omicron Variant
por: Zhao, Xin, et al.
Publicado: (2022)

Structures of Omicron spike complexes and implications for neutralizing antibody development
por: Guo, Hangtian, et al.
Publicado: (2022)

Neutralization and Stability of SARS-CoV-2 Omicron Variant
por: Zeng, Cong, et al.
Publicado: (2021)

Influenza virus infections among patients attending emergency department according to main reason to presenting to ED: A 3-year prospective observational study during seasonal epidemic periods
por: Casalino, Enrique, et al.
Publicado: (2017)

Viral epidemiology and SARS‐CoV‐2 co‐infections with other respiratory viruses during the first COVID‐19 wave in Paris, France
por: Le Hingrat, Quentin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k1n47uh08624bf6q8ns2jqj4d4